SUNCIST: A Study of Calmangafodipir in Healthy Japanese and Caucasian Subjects

Summary

Randomized, double-bline, placebo-controlled, single dose study comparing the pharmacokinetics (PK) and safety of PP095-01 in Japanese and non-Asian (eg, Caucasian) subjects.

Timeline

Start

2017-11-07

Primary completion

2017-12-18

Completion

2017-12-18

Drugs

Indications